The role of 18F-AlF-NOTA-octreotide PET/CT in assessing recurrent carotid body paraganglioma and peptide receptor radionuclide therapy eligibility: A case report
The role of 18F-AlF-NOTA-octreotide PET/CT in assessing recurrent carotid body paraganglioma and peptide receptor radionuclide therapy eligibility: A case report. // Journal of Medical Imaging and Radiation Sciences. – URL: https://www.sciencedirect.com/science/article/pii/S1939865426004364?dgcid=rss_sd_all
The role of 18F-AlF-NOTA-octreotide PET/CT in assessing recurrent carotid body paraganglioma and peptide receptor radionuclide therapy eligibility: A case report. Journal of Medical Imaging and Radiation Sciences. https://www.sciencedirect.com/science/article/pii/S1939865426004364?dgcid=rss_sd_all
“The role of 18F-AlF-NOTA-octreotide PET/CT in assessing recurrent carotid body paraganglioma and peptide receptor radionuclide therapy eligibility: A case report.” Journal of Medical Imaging and Radiation Sciences.
@article{article106532,
title = {The role of 18F-AlF-NOTA-octreotide PET/CT in assessing recurrent carotid body paraganglioma and peptide receptor radionuclide therapy eligibility: A case report},
journal = {Journal of Medical Imaging and Radiation Sciences},
url = {https://www.sciencedirect.com/science/article/pii/S1939865426004364?dgcid=rss_sd_all}
}